Delivery Order SPE2DR25D3004-SPE2DR26FXTJ3
- Not listed
- The Defense Logistics Agency awarded a $13,917.06 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylergonovine 0.2 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of September 25, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,196.66 by the Defense Logistics Agency on December 19, 2025, for the supply of Methylergonovine 0.2 mg/ml in 1 ml vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.28 to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL in vials. This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a competitively awarded, non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution operations....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylergon 0.2mg in a 12-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,142.49 and has an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were utilized for this award,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,794.96 contract is for the delivery of the drug methylergonovine 0.2 mg/ml to support military treatment programs and facilities. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Methylergonovine 0.2 mg tablets in unit dose packaging of 20 tablets. The contract is valued at $5,609.85 with a firm fixed price structure and an ultimate completion date of December 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.24 firm fixed-price contract is for the supply of methylergonovine 0.2 mg/ml ampompoules, a prescription medication. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565735670 - Methylergonovine 0.2 mg/mL vials. The $2,970.20 firm-fixed-price contract has a completion date of September 10, 2024. While this delivery order is not designated as a set-aside, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTJ3Delivery Order
The Defense Logistics Agency awarded a $1,052.10 delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/ml in ampule form, with a completion date of January 12, 2026. The contract was competitively awarded on January 9, 2026, with no set-aside designation, utilizing firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order, with the company's parent entity being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company serves critical customers including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/8/26 |